Momenta Partners With Novartis

Momenta Pharmaceuticals Inc. (MNTA) entered a deal with Novartis AG (NVS) to develop four generic drugs. Shares of Momenta surged $4.97 to close at $18.02 while Novartis stock eased 53 cents to close at $55.44.